Thomas P A Debray1, Yvonne Vergouwe2, Hendrik Koffijberg3, Daan Nieboer2, Ewout W Steyerberg2, Karel G M Moons3. 1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Str. 6.131, PO Box 85500, 3508GA Utrecht, The Netherlands. Electronic address: T.Debray@umcutrecht.nl. 2. Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands. 3. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Str. 6.131, PO Box 85500, 3508GA Utrecht, The Netherlands.
Abstract
OBJECTIVES: It is widely acknowledged that the performance of diagnostic and prognostic prediction models should be assessed in external validation studies with independent data from "different but related" samples as compared with that of the development sample. We developed a framework of methodological steps and statistical methods for analyzing and enhancing the interpretation of results from external validation studies of prediction models. STUDY DESIGN AND SETTING: We propose to quantify the degree of relatedness between development and validation samples on a scale ranging from reproducibility to transportability by evaluating their corresponding case-mix differences. We subsequently assess the models' performance in the validation sample and interpret the performance in view of the case-mix differences. Finally, we may adjust the model to the validation setting. RESULTS: We illustrate this three-step framework with a prediction model for diagnosing deep venous thrombosis using three validation samples with varying case mix. While one external validation sample merely assessed the model's reproducibility, two other samples rather assessed model transportability. The performance in all validation samples was adequate, and the model did not require extensive updating to correct for miscalibration or poor fit to the validation settings. CONCLUSION: The proposed framework enhances the interpretation of findings at external validation of prediction models.
OBJECTIVES: It is widely acknowledged that the performance of diagnostic and prognostic prediction models should be assessed in external validation studies with independent data from "different but related" samples as compared with that of the development sample. We developed a framework of methodological steps and statistical methods for analyzing and enhancing the interpretation of results from external validation studies of prediction models. STUDY DESIGN AND SETTING: We propose to quantify the degree of relatedness between development and validation samples on a scale ranging from reproducibility to transportability by evaluating their corresponding case-mix differences. We subsequently assess the models' performance in the validation sample and interpret the performance in view of the case-mix differences. Finally, we may adjust the model to the validation setting. RESULTS: We illustrate this three-step framework with a prediction model for diagnosing deep venous thrombosis using three validation samples with varying case mix. While one external validation sample merely assessed the model's reproducibility, two other samples rather assessed model transportability. The performance in all validation samples was adequate, and the model did not require extensive updating to correct for miscalibration or poor fit to the validation settings. CONCLUSION: The proposed framework enhances the interpretation of findings at external validation of prediction models.
Authors: Sharon E Davis; Robert A Greevy; Christopher Fonnesbeck; Thomas A Lasko; Colin G Walsh; Michael E Matheny Journal: J Am Med Inform Assoc Date: 2019-12-01 Impact factor: 4.497
Authors: Jeffrey D Long; Douglas R Langbehn; Sarah J Tabrizi; Bernhard G Landwehrmeyer; Jane S Paulsen; John Warner; Cristina Sampaio Journal: Mov Disord Date: 2016-11-28 Impact factor: 10.338
Authors: Philippe Lambin; Ralph T H Leijenaar; Timo M Deist; Jurgen Peerlings; Evelyn E C de Jong; Janita van Timmeren; Sebastian Sanduleanu; Ruben T H M Larue; Aniek J G Even; Arthur Jochems; Yvonka van Wijk; Henry Woodruff; Johan van Soest; Tim Lustberg; Erik Roelofs; Wouter van Elmpt; Andre Dekker; Felix M Mottaghy; Joachim E Wildberger; Sean Walsh Journal: Nat Rev Clin Oncol Date: 2017-10-04 Impact factor: 66.675
Authors: Thomas Pa Debray; Johanna Aag Damen; Richard D Riley; Kym Snell; Johannes B Reitsma; Lotty Hooft; Gary S Collins; Karel Gm Moons Journal: Stat Methods Med Res Date: 2018-07-23 Impact factor: 3.021